BioNTech IMFS at a Glance
For the past two decades, BioNTech IMFS has been at the forefront of providing clinical supply for cell and gene therapy. Today, we are a leader in the development and manufacturing of cell and gene therapy products.
our background
our workplace
our gender
more than 160 passionate employees
infectious retroviral particles produced in 2016
0
product mix manufactured
2015
GMP batches share of total production
2015